BioForm Dermal Filler PMAs Up For FDA Panel Review In August
This article was originally published in The Gray Sheet
Executive Summary
BioForm Medical's premarket approval applications for a dermal filler intended to treat both run-of-the-mill wrinkles and HIV-related facial fat loss will be reviewed by FDA's General & Plastic Surgery Devices Panel Aug. 24